IPCA acquires significant stake in Unichem

IPCA Laboratories is acquiring 33.38% from the promoters of Unichem Laboratories (UL). Promoters before this transaction owned 50.94% of UL. Out of the balance, 9.85% was held by the institutions and 39.21% by the retail investors.  Transaction is announced @ Rs 440/ share aggregating to Rs 1,034.06 cr. This implies a premium of about 17% … Read more

Sanofi to demerge consumer healthcare business

As per newspaper reports, Sanofi India is working on spinning off it’s consumer healthcare business in India in a separate listed entity. The subject unit’s products include leading anti-allergy brands such as Allegra and Avil, pain management drug Combiflam and Vitamin D brand Depura. The business posted revenue of Rs 1,000-1,250 crore in CY22 (against … Read more

Ajanta in keeping with the tradition announces one more buyback

Ajanta Pharma has announced buyback once more. This is 4th year in a row, previous 3 details can be checked here. Current buyback details are – 22,10,500 shares constituting 1.73% of the outstanding capital Buyback price is Rs 1,425/ share which is at 17% premium to the current market price Rs 315 cr will be … Read more

Eris buying a part of dermatology portfolio of Glenmark

Eris Lifesciences is acquiring 9 dermatology brands from Glenmark Pharma. The brands are – Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands. The acquisition is for the India and Nepal Territories Consideration for the transaction is Rs 340 crore payable in cash. Turnover of the acquired brands: FY 20 – … Read more

Advent takes controlling stake in Suven Pharmaceuticals

Private Equity major, Advent has confirmed that it has entered into a definitive agreement to acquire a controlling stake in Suven Pharmaceuticals (SP). Advent is acquiring 50.1% from the promoters (Jasti Property and Equity Holdings Private Limited) at Rs 495/ share totalling Rs 6,313 cr. Above considration is 100% cash payable by Advent to the … Read more

Ajanta Promoters sell some stake. Continue to retain significant.

Ajanta Pharma has informed that two of it’s prom0ter entities have sold stake totalling 4.38% into the Company through open market transactions. Total Promoter stake consequently has reduced from 70.48% to 66.1% Stake has been sold by Aayush M. Agrawal, trustee Aayush Agrawal Trust (3.03%)  and Ravi P. Agrawal, Trustee Ravi Agrawal Trust (1.35%) Reports … Read more

Aster DM forms JV to expand operations into Saudi Arabia

JV has been formed between – Aster Pharmacies Group LLC (APG) – a company registered in Dubai and a material subsidiary of Aster DM Healthcare Limited (ADHL). and Abdulmohsen Al Hokair Holding Group (AAH) – the group was started in 1975 to invest in the sectors of entertainment and hospitality. Group’s projects include 92 entertainment … Read more